PTH and Calcium Synergy for Craniofacial Regeneration
PTH 和钙协同促进颅面再生
基本信息
- 批准号:8435366
- 负责人:
- 金额:$ 37.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-04-01 至 2017-03-31
- 项目状态:已结题
- 来源:
- 关键词:Adverse effectsAnabolic AgentsAnimal ModelBiological AssayBiomimeticsBone GrowthBone RegenerationCalciumCalcium-Sensing ReceptorsCell CycleCellsClinicalCouplingDefectDentalDependenceDevice DesignsDevicesDoseDrug ExposureDrug TargetingEngineeringFDA approvedGene TargetingHealedHealthcareHormonesHumanIn VitroInjection of therapeutic agentKineticsLocal TherapyMediator of activation proteinMedicalMethodsModelingNatural regenerationOralOsteoblastsOsteoclastsOsteogenesisOsteoporosisParathyroid glandPatientsPolymersRattusRegenerative MedicineResearchResearch PersonnelResourcesSiteSystemTNFSF11 geneTechnologyTherapeuticTissue EngineeringTooth ExtractionTranslatingTraumaWidespread DiseaseWorkWound Healingbasebonebone healingcalcium metabolismcalcium phosphateclinical applicationclinically relevantcraniofacialdesigndosageexperiencehealingimprovedin vitro activityin vivoinnovationnanofibernovelosteoclastogenesisprototypescaffoldtargeted delivery
项目摘要
DESCRIPTION (provided by applicant): Craniofacial bone trauma and disease are widespread healthcare problems. Despite the significant healing capability of bone, the requirement for new bone to restore large osseous defects and defects in patients with various medical conditions is a major clinical challenge. Parathyroid hormone (PTH) is currently the only FDA approved anabolic agent to treat osteoporosis in the US, and holds strong promise for craniofacial bone regeneration. Our preliminary studies indicate that a systemic intermittent administration of PTH (daily injection) significantly stimulates bone regeneration in an engineered regenerative medicine model. However, there is no intermittent PTH delivery system available for local delivery applications and furthermore, the mechanisms of action of PTH to stimulate bone regeneration in an osseous wound healing model are unknown. We have developed polymers that enable an implantable prototype device for pulsatile PTH delivery as well as nanofibrous polymer/calcium phosphate composite scaffolds that enhance bone regeneration. Because one of the main functions of PTH is to regulate calcium levels and calcium is pro-proliferative for osteoblastic cells, we hypothesize that the anabolic activity of PTH depends on calcium availability. This proposed research will unite the expertise and resources of two experienced PIs and a Co-I to investigate the synergy between the PTH delivery and calcium availability in a biomimetic scaffold with translational potential for improve craniofacial bone regeneration. We will first develop both pulsatile and continuous PTH delivery systems, nanofibrous polymer/calcium phosphate composite scaffolds with varying calcium availability, and the optimal combination of the PTH delivery and calcium-containing scaffold. We will then investigate the mechanisms of the PTH action in relation to the calcium availability. Finally, based on these understandings we will regenerate craniofacial bone using the developed PTH delivery and scaffold technologies in a clinically relevant tooth extraction wound healing model.
描述(申请人提供):颅面骨创伤和疾病是普遍存在的医疗保健问题。尽管骨具有显著的愈合能力,但在各种疾病的患者中,需要新骨来修复较大的骨缺损和缺陷是一项重大的临床挑战。甲状旁腺激素(PTH)是目前美国FDA批准的唯一用于治疗骨质疏松症的合成代谢药物,对颅面骨再生有很大的希望。我们的初步研究表明,在工程再生医学模型中,系统间歇给药PTH(每日注射)显著刺激骨再生。然而,目前还没有可用于局部给药的间歇性甲状旁腺激素给药系统,此外,甲状旁腺激素在骨伤口愈合模型中刺激骨再生的作用机制尚不清楚。我们已经开发了一种聚合物,可以用于脉动性PTH输送的可植入原型装置,以及纳米纤维聚合物/磷酸钙复合支架,可以增强骨再生。由于甲状旁腺激素的主要功能之一是调节钙水平,而钙对成骨细胞具有促增殖作用,因此我们假设甲状旁腺激素的合成代谢活性取决于钙的可用性。这项拟议的研究将联合两位经验丰富的pi和一位Co-I的专业知识和资源,研究具有改善颅面骨再生转化潜力的仿生支架中PTH递送和钙可用性之间的协同作用。我们将首先开发脉动式和连续式甲状腺激素输送系统,具有不同钙可用性的纳米纤维聚合物/磷酸钙复合支架,以及甲状腺激素输送和含钙支架的最佳组合。然后我们将研究甲状旁腺激素作用与钙可用性的关系。最后,基于这些认识,我们将在临床相关的拔牙伤口愈合模型中使用开发的PTH输送和支架技术再生颅面骨。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PETER X MA其他文献
PETER X MA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PETER X MA', 18)}}的其他基金
Regenerating Hyaline Cartilage Using Nanofibrous Hollow Microspheres and Synergizing TGF-beta and HIF
使用纳米纤维空心微球并协同 TGF-β 和 HIF 再生透明软骨
- 批准号:
10268987 - 财政年份:2020
- 资助金额:
$ 37.32万 - 项目类别:
Nanofibrous self-gelling microspheres for heart regeneration
用于心脏再生的纳米纤维自凝胶微球
- 批准号:
10469629 - 财政年份:2019
- 资助金额:
$ 37.32万 - 项目类别:
PTH and Calcium Synergy for Craniofacial Regeneration
PTH 和钙协同促进颅面再生
- 批准号:
8628665 - 财政年份:2012
- 资助金额:
$ 37.32万 - 项目类别:
PTH and Calcium Synergy for Craniofacial Regeneration
PTH 和钙协同促进颅面再生
- 批准号:
9038175 - 财政年份:2012
- 资助金额:
$ 37.32万 - 项目类别:
PTH and Calcium Synergy for Craniofacial Regeneration
PTH 和钙协同促进颅面再生
- 批准号:
8299750 - 财政年份:2012
- 资助金额:
$ 37.32万 - 项目类别:
Periodontal Engineering Using Biomimetic Nano Scaffolds
使用仿生纳米支架的牙周工程
- 批准号:
7932524 - 财政年份:2009
- 资助金额:
$ 37.32万 - 项目类别:
Orchestrating Bone Regeneration on Multiple Scales
在多个尺度上协调骨再生
- 批准号:
7577467 - 财政年份:2007
- 资助金额:
$ 37.32万 - 项目类别:
Orchestrating Bone Regeneration on Multiple Scales
在多个尺度上协调骨再生
- 批准号:
7259656 - 财政年份:2007
- 资助金额:
$ 37.32万 - 项目类别:
Orchestrating Bone Regeneration on Multiple Scales
在多个尺度上协调骨再生
- 批准号:
7367181 - 财政年份:2007
- 资助金额:
$ 37.32万 - 项目类别:
Orchestrating Bone Regeneration on Multiple Scales
在多个尺度上协调骨再生
- 批准号:
7777855 - 财政年份:2007
- 资助金额:
$ 37.32万 - 项目类别:
相似海外基金
The role of osteoblast progenitors in response to bone anabolic agents
成骨细胞祖细胞对骨合成代谢剂的反应的作用
- 批准号:
10404415 - 财政年份:2023
- 资助金额:
$ 37.32万 - 项目类别:
Characterisation of skeletal development and the use of anabolic agents in murine models of Duchenne muscular dystrophy
杜氏肌营养不良症小鼠模型中骨骼发育的特征和合成代谢药物的使用
- 批准号:
MR/N020588/1 - 财政年份:2016
- 资助金额:
$ 37.32万 - 项目类别:
Fellowship
Application of effect of low-magnitude and high-frequency loading and bone anabolic agents on peri-implant bone in a osteoporosis model
低强度高频负荷和骨合成代谢药物对种植体周围骨的影响在骨质疏松模型中的应用
- 批准号:
15K11148 - 财政年份:2015
- 资助金额:
$ 37.32万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
ASSESSMENT OF ANABOLIC AGENTS AND EXERCISE IN BURNED CHILDREN
烧伤儿童的合成代谢药物和运动评估
- 批准号:
7952148 - 财政年份:2009
- 资助金额:
$ 37.32万 - 项目类别:
ASSESSMENT OF ANABOLIC AGENTS AND EXERCISE IN BURNED CHILDREN
烧伤儿童的合成代谢药物和运动评估
- 批准号:
7719180 - 财政年份:2008
- 资助金额:
$ 37.32万 - 项目类别:
ASSESSMENT OF ANABOLIC AGENTS AND EXERCISE IN BURNED CHILDREN
烧伤儿童的合成代谢药物和运动评估
- 批准号:
7605400 - 财政年份:2007
- 资助金额:
$ 37.32万 - 项目类别:
ASSESSMENT OF ANABOLIC AGENTS AND EXERCISE IN BURNED CHILDREN
烧伤儿童的合成代谢药物和运动评估
- 批准号:
7378734 - 财政年份:2006
- 资助金额:
$ 37.32万 - 项目类别:
ASSESSMENT OF ANABOLIC AGENTS AND EXERCISE IN BURNED CHILDREN
烧伤儿童的合成代谢药物和运动评估
- 批准号:
7202590 - 财政年份:2005
- 资助金额:
$ 37.32万 - 项目类别: